Treatment mechanism of immune triad from the repurposing drug against COVID-19
COVID-19 is an immune-mediated disease whose pathophysiology uses SAMHD1 tetramerization and cGAS–STING signaling, toll-like receptor 4 (TLR4) cascade, spike protein– inflammasome activation, and neuropilin 1 (NRP1) signaling. Variants of concern, such as SARS-CoV-2 Omicron Subvariants BQ.1, BQ.1.1,...
Uloženo v:
| Hlavní autor: | |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
KeAi Communications Co., Ltd.
2023-01-01
|
| Edice: | Translational Medicine of Aging |
| Témata: | |
| On-line přístup: | http://www.sciencedirect.com/science/article/pii/S2468501123000093 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|